Royce & Associates LP lifted its position in inTEST Co. (NYSE:INTT – Free Report) by 9.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,219,157 shares of the company’s stock after acquiring an additional 110,078 shares during the period. Royce & Associates LP owned approximately 9.74% of inTEST worth $8,900,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of INTT. Ground Swell Capital LLC acquired a new stake in shares of inTEST in the 2nd quarter valued at approximately $112,000. Redwood Wealth Management Group LLC acquired a new stake in shares of inTEST in the 2nd quarter valued at approximately $132,000. American Century Companies Inc. acquired a new stake in shares of inTEST in the 2nd quarter valued at approximately $145,000. Allspring Global Investments Holdings LLC raised its holdings in inTEST by 21.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 14,153 shares of the company’s stock worth $188,000 after buying an additional 2,476 shares during the period. Finally, Federated Hermes Inc. acquired a new stake in inTEST during the 2nd quarter worth approximately $436,000. 63.18% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have commented on the stock. Northland Securities raised their target price on shares of inTEST from $10.00 to $13.00 and gave the stock a “market perform” rating in a report on Monday, November 4th. Northland Capmk downgraded shares of inTEST from a “strong-buy” rating to a “hold” rating in a report on Monday, August 5th.
Insider Transactions at inTEST
In related news, CEO Richard N. Jr. Grant sold 6,788 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $6.97, for a total value of $47,312.36. Following the completion of the transaction, the chief executive officer now directly owns 164,929 shares of the company’s stock, valued at approximately $1,149,555.13. This trade represents a 3.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 5.50% of the company’s stock.
inTEST Price Performance
Shares of INTT opened at $7.43 on Monday. The stock has a market capitalization of $91.98 million, a P/E ratio of 32.31 and a beta of 1.92. inTEST Co. has a twelve month low of $6.28 and a twelve month high of $14.35. The company has a 50 day moving average of $7.17 and a 200-day moving average of $8.58. The company has a quick ratio of 1.38, a current ratio of 2.26 and a debt-to-equity ratio of 0.08.
inTEST (NYSE:INTT – Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.03. The company had revenue of $30.27 million during the quarter, compared to analysts’ expectations of $32.97 million. inTEST had a net margin of 2.33% and a return on equity of 5.31%. As a group, equities research analysts forecast that inTEST Co. will post 0.41 EPS for the current fiscal year.
inTEST Company Profile
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Read More
- Five stocks we like better than inTEST
- What Are Growth Stocks and Investing in Them
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Does a Stock Split Mean?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.